Small bowel injury in low-dose aspirin users
Authors:
- 14 December 2014
- journal article
- review article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 50 (4) , 378-386
Abstract
The use of low-dose aspirin (LDA) is well known to be associated with an increased risk of serious upper gastrointestinal complications, such as peptic ulceration and bleeding. Until recently, attention was mainly focused on aspirin-induced damage of the stomach and duodenum. However, recently, there has been growing interest among gastroenterologists on the adverse effects of aspirin on the small bowel, especially as new endoscopic techniques, such as capsule endoscopy (CE) and balloon-assisted endoscopy, have become available for the evaluation of small bowel lesions. Preliminary CE studies conducted in healthy subjects have shown that short-term administration of LDA can induce mild mucosal inflammation of the small bowel. Furthermore, chronic use of LDA results in a variety of lesions in the small bowel, including multiple petechiae, loss of villi, erosions, and round, irregular, or punched-out ulcers. Some patients develop circumferential ulcers with stricture. In addition, to reduce the incidence of gastrointestinal lesions in LDA users, it is important for clinicians to confirm the differences in the gastrointestinal toxicity between different types of aspirin formulations in clinical use. Some studies suggest that enteric-coated aspirin may be more injurious to the small bowel mucosa than buffered aspirin. The ideal treatment for small bowel injury in patients taking LDA would be withdrawal of aspirin, however, LDA is used as an antiplatelet agent in the majority of patients, and its withdrawal could increase the risk of cardiovascular/cerebrovascular morbidity and mortality. Thus, novel means for the treatment of aspirin-induced enteropathy are urgently needed.Keywords
This publication has 76 references indexed in Scilit:
- Effectiveness of polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: a pilot randomized controlled studyBMC Gastroenterology, 2013
- Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopyDigestive and Liver Disease, 2012
- Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing DysbiosisGastroenterology, 2011
- Aspirin-induced small bowel injuries and the preventive effect of rebamipideWorld Journal of Gastroenterology, 2011
- QUANTITATIVE ANALYSIS OF LOW‐DOSE ASPIRIN‐ASSOCIATED SMALL BOWEL INJURY USING A CAPSULE ENDOSCOPY SCORING INDEXDigestive Endoscopy, 2010
- Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of LansoprazoleJournal of Clinical Biochemistry and Nutrition, 2009
- Incidence of Small Bowel Injury Induced by Low-Dose Aspirin: A Crossover Study Using Capsule Endoscopy in Healthy VolunteersDigestion, 2009
- Small Bowel Injury by Low-Dose Enteric-Coated Aspirin and Treatment With Misoprostol: A Pilot StudyClinical Gastroenterology and Hepatology, 2008
- Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDYJournal of Clinical Biochemistry and Nutrition, 2007
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002